Sandri MT - Search Results

1

Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.

Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A. Johansson H, et al. Among authors: sandri mt. Breast Cancer Res Treat. 2008 Mar;108(1):57-67. doi: 10.1007/s10549-007-9577-9. Epub 2007 Apr 28. Breast Cancer Res Treat. 2008. PMID: 17468953

2

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.

Decensi A, Omodei U, Robertson C, Bonanni B, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Mora S, Sandri MT, Cazzaniga M, Franchi M, Pecorelli S. Decensi A, et al. Among authors: sandri mt. Circulation. 2002 Sep 3;106(10):1224-8. doi: 10.1161/01.cir.0000028463.74880.ea. Circulation. 2002. PMID: 12208797 Clinical Trial.

3

A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.

Decensi A, Robertson C, Viale G, Pigatto F, Johansson H, Kisanga ER, Veronesi P, Torrisi R, Cazzaniga M, Mora S, Sandri MT, Pelosi G, Luini A, Goldhirsch A, Lien EA, Veronesi U. Decensi A, et al. Among authors: sandri mt. J Natl Cancer Inst. 2003 Jun 4;95(11):779-90. doi: 10.1093/jnci/95.11.779. J Natl Cancer Inst. 2003. PMID: 12783932 Free article. Clinical Trial.

4

Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma.

Sandri MT, Johansson H, Colleoni M, Zorzino L, Passerini R, Orlando L, Viale G. Sandri MT, et al. Anticancer Res. 2004 Mar-Apr;24(2C):1261-6. Anticancer Res. 2004. PMID: 15154657 Free article. Clinical Trial.

5

A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.

Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U. Decensi A, et al. Among authors: sandri mt. Clin Cancer Res. 2004 Jul 1;10(13):4389-97. doi: 10.1158/1078-0432.CCR-04-0087. Clin Cancer Res. 2004. PMID: 15240527 Clinical Trial.

6

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.

Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A. Johansson H, et al. Among authors: sandri mt. Breast Cancer Res Treat. 2004 Nov;88(1):63-73. doi: 10.1007/s10549-004-0746-9. Breast Cancer Res Treat. 2004. PMID: 15538047

7

Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer.

Johansson H, Bonanni B, Mariette F, Cazzaniga M, Baglietto L, Guerrieri-Gonzaga A, Sandri MT, Luini A, Pelosi G, Decensi A. Johansson H, et al. Among authors: sandri mt. Breast Cancer Res Treat. 2006 Jul;98(2):167-72. doi: 10.1007/s10549-005-9145-0. Epub 2006 Mar 15. Breast Cancer Res Treat. 2006. PMID: 16538534 Clinical Trial.

8

Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy.

Sandri MT, Johansson HA, Zorzino L, Salvatici M, Passerini R, Maisonneuve P, Rocca A, Peruzzotti G, Colleoni M. Sandri MT, et al. Cancer. 2007 Aug 1;110(3):509-17. doi: 10.1002/cncr.22825. Cancer. 2007. PMID: 17559147 Free article. Clinical Trial.

9

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

Botteri E, Sandri MT, Bagnardi V, Munzone E, Zorzino L, Rotmensz N, Casadio C, Cassatella MC, Esposito A, Curigliano G, Salvatici M, Verri E, Adamoli L, Goldhirsch A, Nolè F. Botteri E, et al. Among authors: sandri mt. Breast Cancer Res Treat. 2010 Jul;122(1):211-7. doi: 10.1007/s10549-009-0668-7. Epub 2009 Dec 6. Breast Cancer Res Treat. 2010. PMID: 19967556

10

Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer.

Rocca A, Cancello G, Bagnardi V, Sandri MT, Torrisi R, Zorzino L, Viale G, Pietri E, Veronesi P, Dellapasqua S, Ferrucci F, Luini A, Johansson H, Ghisini R, Goldhirsch A, Colleoni M. Rocca A, et al. Among authors: sandri mt. Anticancer Res. 2009 Dec;29(12):5111-9. Anticancer Res. 2009. PMID: 20044624 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page